St Pharm Co., Ltd. · KRX:237690

St Pharm Co., Ltd. financial statements

St Pharm Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue331.7B273.8B285.0B249.3B165.6B124.1B93.3B97.7B202.8B200.4B
Cost of revenue195.5B177.6B172.9B160.4B107.9B104.1B94.9B95.0B123.0B107.4B
Gross profit136.2B96.2B112.1B88.9B57.7B20.0B-1.63B2.78B79.8B93.0B
Research and development23.7B22.1B30.4B26.3B18.2B13.2B15.1B8.77B9.66B8.58B
Selling, general and administrative12.6B42.5B44.7B40.3B31.1B23.0B9.49B9.47B8.15B6.76B
Operating income54.9B27.6B33.5B17.9B5.58B-18.8B-26.7B-15.6B61.2B77.6B
Depreciation and amortization29.9B24.6B23.0B17.0B14.4B14.1B11.2B9.23B11.6B10.8B
EBITDA84.8B52.2B56.5B34.8B20.0B-4.75B-15.5B-6.42B72.7B88.3B
Interest expense4.04B7.74B6.11B2.87B5.16B644.6M0000
Income before tax58.7B42.7B23.4B19.2B1.26B-16.8B-25.0B-13.4B59.2B80.5B
Income tax-2.12B-3.67B-6.44B-4.12B14.2B19.1B
Net income55.0B34.7B19.6B18.0B3.31B-12.1B-18.5B-9.27B45.0B61.4B
Earnings per share, basic2,656.951,722.421,041.07957.00176.09-651.11-993.18-496.782,411.933,323.12

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents30.5B63.4B50.1B50.2B27.3B8.70B74.7M47.7B72.3B55.2B
Short-term investments60.4B57.5B40.0B1054.0B102.0B38.2B60.0B60.0B60.0B
Receivables96.7B67.8B120.6B94.2B62.9B45.4B35.7B15.9B31.7B13.7B
Inventory169.5B127.0B120.7B107.6B80.8B45.4B40.9B40.7B58.0B91.4B
Current assets372.7B330.1B348.4B263.2B244.1B235.6B144.2B167.3B225.2B224.9B
Property, plant and equipment338.7B280.1B257.9B210.2B175.6B171.0B169.1B151.6B138.4B
Goodwill11.8B10.6B9.95B8.95B8.46B8.04B6.69B
Total assets782.6B721.9B675.4B570.7B498.6B445.6B341.1B345.5B381.5B367.8B
Accounts payable11.8B10.6B17.7B18.1B12.9B4.69B7.16B3.09B3.11B13.7B
Current liabilities164.8B133.3B83.7B179.2B75.4B18.6B16.2B9.95B28.6B51.5B
Long-term debt43.3B159.7B16.7B91.5B125.6B15.1B97.5M117.0M136.5M
Total debt126.0B15.6B
Total liabilities189.6B218.9B288.5B233.0B175.6B150.2B40.1B13.9B30.4B54.5B
Shareholders' equity593.4B503.1B384.6B337.6B323.0B295.3B301.0B331.6B351.1B313.2B
Shares outstanding20.7M20.2M18.8M18.8M18.8M18.7M18.7M18.7M18.7M18.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations14.0B109.5B1.30B7.03B7.27B-20.9B-30.5B10.8B54.4B50.8B
Capital spending-47.3B-83.2B-43.4B-60.7B-51.8B-17.0B-6.22B-27.2B-27.7B-16.0B
Free cash flow-33.3B26.2B-42.1B-53.6B-44.6B-38.4B-36.7B-16.4B26.7B34.7B
Cash from investing-86.5B-82.4B-5.72B-8.03B-69.1B-9.77B-26.8B-26.3B-93.2B
Cash from financing-11.0B81.4B10.8B-115.6M115.9B5.32B-9.01B-9.13B85.2B
Dividends paid-10.1B-9.40B-9.40B-9.40B-9.33B-9.33B-9.24B-2.95B
Share buybacks1.15B132.2B
Change in cash-32.9B13.3B-103.9M11.0B578.2M25.8B-34.9B-24.6B17.1B43.4B